ClinicalTrials.gg
Sign In
CompletedNCT01746407EMOSUpdated Dec 30, 2015

Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis

An observational study in Infection, sponsored by Abbott Diagnostics Division. Completed at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-12-30.

Primary conditionSepsisRegistry: InfectionsReclassifiedWhy we changed it
Registry
Infections — the first condition term the registry derived for this study.
ClinicalTrials.gg
Sepsis
Why
  1. The study's title name Sepsis, a narrower term within Infections.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Abbott Diagnostics Division (part of Abbott) · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
872
Ages
18 Years and older
Sex
All
01

Study summary

Procure blood specimens from individuals presenting to the emergency department (ED) with signs and /or symptoms of systemic infection or sepsis. The samples will be used for research and development activities related to sepsis, infections, etc.

02

Conditions studied

  • Infection

Browse trials for

Keywords

  • Emergency Department
  • Infection
  • Sepsis
03

In context

Sepsis Reclassified

2,416 studies on the registry are indexed under Sepsis; 541 are open to participants now.

This study's enrollment of 872 is above the median of 150 across 1,162 observational studies indexed under Sepsis.

Browse Sepsis studies →

Lead sponsor

Abbott Diagnostics Division is the lead sponsor of 8 studies on the registry; none are open to participants now.

Browse Abbott Diagnostics Division studies →All Abbott studies →

Compared within Sepsis, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Infections. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Presentation to an emergency department

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 yrs of age or older
  • For women of child bearing years: not known to be pregnant
  • Blood culture ordered as part of the ED, ICU (or equivalent) or hospital floor stay.

Exclusion criteria

Exclusion Criteria:

  • Previously enrolled in this study
  • Vulnerable individual
  • Unable to speak and/or understand English
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
872 participants (actual)
Biospecimen retention
Samples without dna
06

What researchers measure

Primary outcomes

  1. Progression of infection to severe sepsis

    Assessment of the progression of infection to severe sepsis in an ED population who present with signs or symptoms of infection.

    Time frame: 72 hours

07

Study locations

2 sites
  • Emory University Hospital
    Atlanta, Georgia 30303, United States
  • Grady Memorial Hospital
    Atlanta, Georgia 30303, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 30, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01746407
Lead sponsor
Abbott Diagnostics Division
Responsible party
Sponsor
First posted
Dec 11, 2012
Start date
Dec 2012
Primary completion
Aug 2014
Completion
Dec 2014
Last update
Dec 30, 2015

Study contacts

Greg S Martin, MD, M.Sc.
principal investigator · Emory University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Sepsis →

Other studies from this sponsor

Abbott Diagnostics Division →

Start the discussion